Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System

• 主要な著者: Elena Mirabela Velișcu (著者), Valerio Liguori (著者), Antonietta Anatriello (著者), Giorgia Teresa Maniscalco (著者), Andrea Cantone (著者), Luigi Di Costanzo (著者), Pasquale Stefanelli (著者), Cristina Scavone (著者), Annalisa Capuano (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2023-07-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background. Cladribine belongs to the group of disease-modifying therapies (DMTs) used to treat multiple sclerosis (MS). According to the highlights of a meeting held by the Pharmacovigilance Risk Assessment Committee (PRAC) on 14 January 2022, cladribine may be associated with the occurrence of liv...